Vertigo, a common clinical symptom, often presents a diagnostic challenge due to its multifaceted nature. This symptom, characterized by a sensation of self-motion or environmental motion, is frequently a manifestation of vestibular disorders. Understanding its pathophysiology and clinical presentation can enhance diagnostic accuracy and patient management.
Vertigo is primarily a symptom of vestibular dysfunction, resulting from diverse etiologies such as benign paroxysmal positional vertigo (BPPV), Meniere's disease, or vestibular neuritis. It can also occur secondary to central nervous system disorders like stroke or multiple sclerosis. A careful history and physical examination are critical in differentiating peripheral from central causes of vertigo.
When evaluating a patient with vertigo, a systematic approach is crucial. The patient's history should focus on the onset, duration, and triggers of vertigo. Physical examination should include a detailed neurological and otoscopic assessment. Special attention should be given to nystagmus, head impulse test, and Romberg's test. Audiometric testing and neuroimaging may also be necessary for definitive diagnosis.
Management of vertigo depends on the underlying cause. BPPV, the most common cause of vertigo, is typically managed with canalith repositioning maneuvers. Meniere's disease may require dietary modifications, diuretics, and possibly surgery. Vestibular neuritis often responds to corticosteroids and vestibular rehabilitation. In cases of central vertigo, the underlying neurological condition must be addressed.
Vertigo is a common yet complex clinical symptom requiring a comprehensive and systematic approach for accurate diagnosis and effective management. By understanding the pathophysiology and adopting a thorough clinical evaluation strategy, healthcare professionals can enhance patient outcomes and reduce the burden of this disabling condition.
1.
Race, Geography Linked to Gaps in Prostate Cancer Care
2.
Sports for girls are frequently abandoned due to uniform issues.
3.
According to the Lancet, having cancer and VTE at the same time increases mortality risk.
4.
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer
5.
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma
1.
Hematopoietic Clonal Competition in Blood Disorders
2.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
3.
Developmental Iron Biology Beyond Infancy: Mechanisms, Clinical Implications, and Emerging Directions
4.
Next-Generation Bone Marrow Harvest Technologies
5.
Strategic Applications in Hematology in Clinical Decision-Making
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding the Common Causes of Anemia
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation